Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Oncology Information Systems Market, by Offering
1.4.2 Europe Oncology Information Systems Market, by Application
1.4.3 Europe Oncology Information Systems Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2018, Mar – 2022, May) Leading Players
Chapter 4. Europe Oncology Information Systems Market by Offering
4.1 Europe Solutions Market by Country
4.2 Europe Oncology Information Systems Market by Solutions Type
4.2.1 Europe Patient Information Systems Market by Country
4.2.2 Europe Treatment Planning Systems Market by Country
4.3 Europe Professional Services Market by Country
Chapter 5. Europe Oncology Information Systems Market by Application
5.1 Europe Medical Oncology Market by Country
5.2 Europe Radiation Oncology Market by Country
5.3 Europe Surgical Oncology Market by Country
Chapter 6. Europe Oncology Information Systems Market by Country
6.1 Germany Oncology Information Systems Market
6.1.1 Germany Oncology Information Systems Market by Offering
6.1.1.1 Germany Oncology Information Systems Market by Solutions Type
6.1.2 Germany Oncology Information Systems Market by Application
6.2 UK Oncology Information Systems Market
6.2.1 UK Oncology Information Systems Market by Offering
6.2.1.1 UK Oncology Information Systems Market by Solutions Type
6.2.2 UK Oncology Information Systems Market by Application
6.3 France Oncology Information Systems Market
6.3.1 France Oncology Information Systems Market by Offering
6.3.1.1 France Oncology Information Systems Market by Solutions Type
6.3.2 France Oncology Information Systems Market by Application
6.4 Russia Oncology Information Systems Market
6.4.1 Russia Oncology Information Systems Market by Offering
6.4.1.1 Russia Oncology Information Systems Market by Solutions Type
6.4.2 Russia Oncology Information Systems Market by Application
6.5 Spain Oncology Information Systems Market
6.5.1 Spain Oncology Information Systems Market by Offering
6.5.1.1 Spain Oncology Information Systems Market by Solutions Type
6.5.2 Spain Oncology Information Systems Market by Application
6.6 Italy Oncology Information Systems Market
6.6.1 Italy Oncology Information Systems Market by Offering
6.6.1.1 Italy Oncology Information Systems Market by Solutions Type
6.6.2 Italy Oncology Information Systems Market by Application
6.7 Rest of Europe Oncology Information Systems Market
6.7.1 Rest of Europe Oncology Information Systems Market by Offering
6.7.1.1 Rest of Europe Oncology Information Systems Market by Solutions Type
6.7.2 Rest of Europe Oncology Information Systems Market by Application
Chapter 7. Company Profiles
7.1 Oracle Corporation (Cerner Corporation)
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Product Launches and Product Expansions:
7.1.5.3 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Koninklijke Philips N.V. (Philips Healthcare)
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Product Launches and Product Expansions:
7.2.5.3 Acquisition and Mergers:
7.3 Varian Medical Systems, Inc. (Siemens Healthineers)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.4 ViewRay, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.5 Accuray Incorporated
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Acquisition and Mergers:
7.6 Elekta AB
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expense
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Acquisition and Mergers:
7.7 RaySearch Laboratories AB (Nasdaq, Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Product Launches and Product Expansions:
7.8 Brainlab AG
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Partnerships, Collaborations, and Agreements:
7.8.2.2 Acquisition and Mergers:
7.9 DOSIsoft SA (Institut de cancérologie Gustave Roussy)
7.9.1 Company Overview
7.10. MIM Software Inc.
7.10.1 Company Overview
Unique Offerings 